For patients with breast cancer to play active roles in treatment decisions, they must understand their risk of cancer recurrence and how that risk changes with different treatments. Such information is available to treating clinicians through tools such as AdjuvantOnline,1,2 and the use of such tools may reduce patient selection of treatments with low risk reduction.3,4 Our objective was to identify how often medical oncologists and surgeons use such tools or provide patients diagnosed as having breast cancer with detailed recurrence risk information, as well as to explore what clinician characteristics influence these behaviors.
Zikmund-Fisher BJ, Janz NK, Hawley ST, Griffith KA, Sabolch A, Jagsi R. Communication of Recurrence Risk Estimates to Patients Diagnosed With Breast Cancer . JAMA Oncol. 2016;2(5):684-686. doi:10.1001/jamaoncol.2015.6416